• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过应用 miR-34a 相关间充质干细胞条件培养基改变肿瘤微环境:调节乳腺癌细胞向非侵袭性行为。

Tumor Microenvironment Changing through Application of MicroRNA-34a Related Mesenchymal Stem Cells Conditioned Medium: Modulation of Breast Cancer Cells toward Non-aggressive Behavior.

机构信息

Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.

出版信息

Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):221-232.

PMID:33904680
Abstract

Conditioned medium (CM) derived from mesenchymal stem cells (MSCs) contains bioactive molecules including microRNAs (miRs) that could be a potential tool for controlling cancer cells' behavior. Due to the properties of CM, this study assesses the effects of miR-34a related MSC-CM on tumor behavior through the evaluation of migration, invasion, apoptosis, and PDL1 expression in breast cancer cell lines. The miR-34a overexpression vector or scramble control was produced using lentiviral vectors, DNA cloning, and the transfection of the HEK-293T cell line. It was then transduced into human adipose-derived mesenchymal stem cells (hAD-MSCs). MSC-CMs were collected and added onto MDA-MB-231 cell lines. The functional evaluations were performed by transwell, wound healing, and Annexin V/PI methods on the treated MDA-MB-231 cell lines. The PDL1 expression was also assessed by Real-time PCR and western blot. The findings of this study showed that ectopic miR‑34a expression was significantly upregulated in manipulated hASC with miR-34a (p<0.0001). Treatment of MDA-MB-231 cell line with miR-34a-hAD-MSC-CM, scramble-hAD-MSC-CM, or hAD-MSC-CM displayed not only a reduction in the number of migrated or invaded cells (p=0.01) but also an increase in the apoptotic cells in the test group (p=0.02) when compared to the control groups. It also showed down-regulation in the gene (p=0.05) and protein expression levels of PDL1 in the test group. The results of the present study showed that simultaneous application of miR-34a and MSC-CM can be considered as a new method for changing the cancerous microenvironment; and therefore, as a potential strategy in breast cancer therapy.

摘要

条件培养基(CM)来源于间充质干细胞(MSCs),其中包含生物活性分子,包括 microRNAs(miRs),这可能是控制癌细胞行为的潜在工具。由于 CM 的特性,本研究通过评估乳腺癌细胞系的迁移、侵袭、凋亡和 PDL1 表达,评估 miR-34a 相关 MSC-CM 对肿瘤行为的影响。使用慢病毒载体、DNA 克隆和 HEK-293T 细胞系转染产生 miR-34a 过表达载体或 scramble 对照。然后将其转导到人脂肪来源的间充质干细胞(hAD-MSCs)中。收集 MSC-CM 并添加到 MDA-MB-231 细胞系上。通过 Transwell、划痕愈合和 Annexin V/PI 方法对处理后的 MDA-MB-231 细胞系进行功能评估。还通过 Real-time PCR 和 Western blot 评估 PDL1 表达。本研究的结果表明,外源性 miR-34a 在经 miR-34a 处理的操纵 hASC 中表达显著上调(p<0.0001)。与对照组相比,用 miR-34a-hAD-MSC-CM、 scramble-hAD-MSC-CM 或 hAD-MSC-CM 处理 MDA-MB-231 细胞系不仅减少了迁移或侵袭细胞的数量(p=0.01),而且增加了实验组的凋亡细胞(p=0.02)。还显示实验组 PDL1 的基因(p=0.05)和蛋白表达水平下调。本研究结果表明,同时应用 miR-34a 和 MSC-CM 可以被认为是改变癌症微环境的一种新方法;因此,它可能成为乳腺癌治疗的一种潜在策略。

相似文献

1
Tumor Microenvironment Changing through Application of MicroRNA-34a Related Mesenchymal Stem Cells Conditioned Medium: Modulation of Breast Cancer Cells toward Non-aggressive Behavior.通过应用 miR-34a 相关间充质干细胞条件培养基改变肿瘤微环境:调节乳腺癌细胞向非侵袭性行为。
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):221-232.
2
Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.百里醌处理的小鼠间充质干细胞条件培养基在体外抑制人乳腺癌细胞。
Chem Biol Interact. 2023 Jan 5;369:110283. doi: 10.1016/j.cbi.2022.110283. Epub 2022 Nov 28.
3
N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.N-钙黏蛋白介导骨髓间充质干细胞向乳腺癌细胞的迁移。
Theranostics. 2021 May 3;11(14):6786-6799. doi: 10.7150/thno.59703. eCollection 2021.
4
Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.间充质干细胞来源的微小囊泡过表达 miR-34a 抑制转化生长因子-β1 诱导的肾小管上皮细胞上皮-间充质转化。
Chin Med J (Engl). 2020 Apr 5;133(7):800-807. doi: 10.1097/CM9.0000000000000720.
5
Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.脐带间充质干细胞通过激活ERK信号通路促进MCF-7和MDA-MB-231乳腺癌细胞的增殖和迁移。
Oncol Rep. 2015 Sep;34(3):1469-77. doi: 10.3892/or.2015.4109. Epub 2015 Jul 3.
6
MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment.miR-34a 通过调节免疫微环境中的 PDL1 抑制胃癌的增殖和侵袭。
Mol Cell Probes. 2020 Oct;53:101601. doi: 10.1016/j.mcp.2020.101601. Epub 2020 May 20.
7
Suppressive effect of exogenous miR-16 and miR-34a on tumorigenesis of breast cancer cells.外源性 miR-16 和 miR-34a 对乳腺癌细胞发生的抑制作用。
J Cell Biochem. 2019 Aug;120(8):13342-13353. doi: 10.1002/jcb.28608. Epub 2019 Mar 27.
8
Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells.间充质干细胞通过分泌 CCL5 诱导乳腺癌细胞表达 PD-L1。
J Cell Physiol. 2021 May;236(5):3918-3928. doi: 10.1002/jcp.30135. Epub 2020 Nov 4.
9
IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.侵袭性乳腺癌细胞产生的白细胞介素-1β是通过趋化因子产生来决定其与间充质干细胞相互作用的因素之一。
Oncotarget. 2015 Oct 6;6(30):29034-47. doi: 10.18632/oncotarget.4732.
10
MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.miR-383-5p 通过抑制 PD-L1 抑制乳腺癌细胞增殖、迁移并促进其凋亡。
Life Sci. 2021 Feb 15;267:118939. doi: 10.1016/j.lfs.2020.118939. Epub 2020 Dec 23.

引用本文的文献

1
MSCs engineered with secreted Klotho alleviate blood-brain barrier disruption and reduce neuroinflammation more effectively than MSCs in experimental autoimmune encephalomyelitis.经分泌型Klotho基因工程改造的间充质干细胞在实验性自身免疫性脑脊髓炎中比间充质干细胞更有效地减轻血脑屏障破坏并减少神经炎症。
Stem Cell Res Ther. 2025 Jul 1;16(1):346. doi: 10.1186/s13287-025-04428-w.
2
MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.微小 RNA34a 与骨肉瘤患者的化疗耐药性、转移、复发、生存和预后相关。
Medicine (Baltimore). 2022 Sep 23;101(38):e30722. doi: 10.1097/MD.0000000000030722.
3
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
PD-L1 抑制性 microRNAs 治疗三阴性乳腺癌的系统评价:迈向单细胞测序指导的仿生递药。
Genes (Basel). 2021 Aug 4;12(8):1206. doi: 10.3390/genes12081206.